Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 49, 2008, Pages 19468-19473

  Schröer, Jörg ^a,b   Shenk, Thomas ^a  

^a PRINCETON UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Cyclooxygenase inhibitors; Human cytomegalovirus pathogenesis

Indexed keywords

INDOMETACIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TOLFENAMIC ACID;

ARTICLE; CELL COMMUNICATION; CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS REPLICATION;

ANTHRANILIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DINOPROSTONE; DRUG INTERACTIONS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INDOMETHACIN; SKIN; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 5;

EID: 58049218907     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0810740105     Document Type: Article

References (62)

1. Mocarski ES, Shenk T, Pass RF (2007) in Cytomegaloviruses (Lippincott Williams and Wilkins, Philadelphia, PA).
2. Biron KK (2006) Antiviral drugs for cytomegalovirus diseases. Antiviral Res 71:154-163.
3. Noble S, Faulds D (1998) Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 56:115-146.
4. Deray G, et al. (1989) Foscarnet nephrotoxicity: Mechanism, incidence and prevention. Am J Nephrol 9:316-321.
5. De Clercq E, Holy A (2005) Acyclic nucleoside phosphonates: A key class of antiviral drugs. Nat Rev Drug Discov 4:928-940.
6. Ho ES, Lin DC, Mendel DB, Cihlar T (2000) Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11:383-393.
7. Field AK, Biron KK (1994) "The end of innocence" revisited: Resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev 7:1-13.
8. Biron KK, et al. (2002) Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother 46:2365-2372.
9. Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE (2002) Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA 99:3932-3937.
10. Speir E, Yu ZX, Ferrans VJ, Huang ES, Epstein SE (1998) Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 83:210-216.
11. Reynolds AE, Enquist LW (2006) Biological interactions between herpesviruses and cyclooxygenase enzymes. Rev Med Virol 16:393-403.
12. Steer SA, Corbett JA (2003) The role and regulation of COX-2 during viral infection. Viral Immunol 16:447-460.
13. Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: Structures, properties, and functions. Physiol Rev 79:1193-1226.
14. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 69:145-182.
15. Chandrasekharan NV, et al. (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931.
16. DeWitt DL, Smith WL (1988) Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 85:1412-1416.
17. DeWitt DL, Smith WL (1990) Cloning of sheep and mouse prostaglandin endoperoxide synthases. Methods Enzymol 187:469-479.
18. Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA (1991) Human platelet/erythroleukemia cell prostaglandin G/H synthase: CDNA cloning, expression, and gene chromosomal assignment. FASEB J 5:2304-2312.
19. Chen N, Reis CS (2002) Distinct roles of eicosanoids in the immune response to viral encephalitis: Or why you should take NSAIDS. Viral Immunol 15:133-146.
20. AbuBakar S, Boldogh I, Albrecht T (1990) Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase C. Biochem Biophys Res Commun 166:953-959.
21. AbuBakar S, Boldogh I, Albrecht T (1990) Human cytomegalovirus. Stimulation of [3H] release from [3H]-arachidonic acid prelabelled cells. Arch Virol 113:255-266.
22. Browne EP, Wing B, Coleman D, Shenk T (2001) Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: Viral block to the accumulation of antiviral mRNAs. J Virol 75:12319-12330.
23. Simmen KA, et al. (2001) Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci USA 98:7140-7145.
24. Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T (1998) Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA 95:14470-14475.
25. Hansen SG, Strelow LI, Franchi DC, Anders DG, Wong SW (2003) Complete sequence and genomic analysis of rhesus cytomegalovirus. J Virol 77:6620-6636.
26. Rue CA, et al. (2004) A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol 78:12529-12536.
27. Tanaka J, Ogura T, Iida H, Sato H, Hatano M (1988) Inhibitors of prostaglandin synthesis inhibit growth of human cytomegalovirus and reactivation of latent virus in a productively and latently infected human cell line. Virology 163:205-208.
28. Ray N, Bisher ME, Enquist LW (2004) Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J Virol 78:12964-12974.
29. Mocarski ES, Jr. (2002) Virus self-improvement through inflammation: No pain, no gain. Proc Natl Acad Sci USA 99:3362-3364.
30. Pedersen SB (1994) Biopharmaceutical aspects of tolfenamic acid. Pharmacol Toxicol 75 Suppl 2:22-32.
31. Vapaatalo H, Parantainen H, Linden IB, Hakkarainen H (1977) in Headache, New Vistas, Proceedings of the Joint Meeting of the Italian Headache and the Scandinavian Migraine Societies (Florence).
32. Moilanen E, Alanko J, Seppala E, Vapaatalo H (1988) Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Agents Actions 24:387-394.
33. Moilanen E, Alanko J, Juhakoski A, Vapaatalo H (1989) Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes. Agents Actions 28:83-88.
34. Sanchez V, Greis KD, Sztul E, Britt WJ (2000) Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: Characterization of a potential site of virus assembly. J Virol 74:975-986.
35. Digel M, Sampaio KL, Jahn G, Sinzger C (2006) Evidence for direct transfer of cytoplasmic material from infected to uninfected cells during cell-associated spread of human cytomegalovirus. J Clin Virol 37:10-20.
36. Moll M, Pfeuffer J, Klenk HD, Niewiesk S, Maisner A (2004) Polarized glycoprotein targeting affects the spread of measles virus in vitro and in vivo. J Gen Virol 85:1019-1027.
37. Firsching R, Buchholz CJ, Schneider U, Cattaneo R, ter Meulen V, Schneider-Schaulies J (1999) Measles virus spread by cell- cell contacts: Uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J Virol 73:5265-5273.
38. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 199:283-293.
39. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, Mothes W (2007) Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol 9:310-315.
40. Johnson DC, Webb M, Wisner TW, Brunetti C (2001) Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread. J Virol 75:821-833.
41. Krummenacher C, Baribaud I, Eisenberg RJ, Cohen GH (2003) Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection. J Virol 77:8985-8999.
42. Sinzger C, et al. (1999) Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 80(Pt 11):2867-2877.
43. Yamane Y, Furukawa T, Plotkin SA (1983) Supernatant virus release as a differentiating marker between low passage and vaccine strains of human cytomegalovirus. Vaccine 1:23-25.
44. Sinzger C, et al. (2007) Effect of serum and CTL on focal growth of human cytomegalovirus. J Clin Virol 38:112-119.
45. Gerna G, et al. (2000) Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 74:5629-5638.
46. Silva MC, Yu QC, Enquist L, Shenk T (2003) Human cytomegalovirus UL99-encoded pp28 is required for the cytoplasmic envelopment of tegument-associated capsids. J Virol 77:10594-10605.
47. Silva MC, Schroer J, Shenk T (2005) Human cytomegalovirus cell-to-cell spread in the absence of an essential assembly protein. Proc Natl Acad Sci USA 102:2081-2086.
48. Barnett J, et al. (1994) Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system. Biochim Biophys Acta 1209:130-139.
49. Sifton DW (2003) in Physicians' Desk Reference. 57 Edition (Thomson, Montvale).
50. Walter EA, et al. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333:1038-1044.
51. Einsele H, et al. (2002) Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99:3916-3922.
52. Nigro G, Adler SP, La Torre R, Best AM (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350-1362.
53. Valantine HA (1995) Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: Evidence for a beneficial effect of hyperimmune globulin. Transplant Proc 27:49-57.
54. Bonaros N, Mayer B, Schachner T, Laufer G, Kocher A (2008) CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: A meta-analysis. Clin Transplant 22:89-97.
55. Gebhardt BM, Varnell ED, Kaufman HE (2005) Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 21:114-120.
56. Inglot AD, Woyton A (1971) Topical treatment of cutaneous herpes simplex in humans with the non-steroid antiinflammatory drugs: Mefenamic acid and indomethacin in dimethylsulfoxide. Arch Immunol Ther Exp (Warsz) 19:555-566.
57. Wachsman M, Aurelian L, Burnett JW (1990) The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections. Br J Dermatol 123:375-380.
58. Yu D, Smith GA, Enquist LW, Shenk T (2002) Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J Virol 76:2316-2328.
59. Terhune SS, Schroer J, Shenk T (2004) RNAs are packaged into human cytomegalovirus virions in proportion to their intracellular concentration. J Virol 78:10390-10398.
60. Feng X, Schroer J, Yu D, Shenk T (2006) Human cytomegalovirus pUS24 is a virion protein that functions very early in the replication cycle. J Virol 80:8371-8378.
61. Zhu H, Shen Y, Shenk T (1995) Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol 69:7960-7970.
62. Nowak B, et al. (1984) Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins. Virology 132:325-338.